PROFILE OF PULMONARY AND EXTRA PULMONARY TUBERCULOSIS USE GENEXPER AT THE PIRNGADI HOSPITAL MEDAN


Eva Sartika Daposang(1*), Fenny Hasanah(2), Dewi Silaban(3),


(1) Universitas Tjut Nyak Dhien
(2) Universitas Tjut Nyak Dhien
(3) Universitas Tjut Nyak Dhien
(*) Corresponding Author

Abstract


Mycobacterium tuberculosis as the bacteria that causes TB disease where the healing process takes a long time, using boredom and drug blockages in TB sufferers. This is one reason germs become resistant to several types of anti-tuberculosis drugs known as TB Multi Drug Resistance (MDR TB). The molecular rapid test (TCM) method using GenExper can quickly determine ATD resistance. This study aims to see the results of TCM examination using GenExper in patients with pulmonary tuberculosis and extra pulmonary tuberculosis at dr. Pirngadi Medan. This study used a cross-sectional method by taking laboratory data from the GenExper examination contained in the medical records of patients diagnosed with tuberculosis at Pirngadi Hospital, Medan. Samples obtained from patients using GenExper from January to December 2018 obtained 354 patients with 68.1% more TB incidence in male patients (241/354) than women by 31.9% (113/354). The patients most affected by TB were elderly people aged 56-65 years with a proportion of 23.7%. The largest population affected by TB is self-employed 30.5% and the highest level of education diagnosed is high school graduates 60.5%. Most patients suffered from pulmonary TB at 86.4%.

Keywords


Tuberculosis; Multi Drug Resistence; GenExper

Full Text:

PDF

References


Andayani, S., & Astuti, Y. (2017). PREDIKSI KEJADIAN PENYAKIT TUBERKULOSIS PARU BERDASARKAN USIA DI KABUPATEN PONOROGO TAHUN 2016-2020. Indonesian Journal for Health Sciences. https://doi.org/10.24269/ijhs.v1i2.482

DASOPANG, E. S., HASANAH, F., FAUZIAH, I., SALMAN, S., & BAKRI, T. K. (2020). Potential side effects of medicine on patients with tuberculosis fixed-dose combination in dr. Pirngadi Hospital, Medan. Jurnal Natural. https://doi.org/10.24815/jn.v20i1.15285

Dasopang, E. S., Hasanah, F., & Nisak, C. (2019). ANALISIS DESKRIPTIF EFEK SAMPING PENGGUNAAN OBAT ANTI TUBERCULOSIS PADA PASIEN TBC DI RSUD Dr. PIRNGADI MEDAN. Jurnal Penelitian Farmasi & Herbal. https://doi.org/10.36656/jpfh.v2i1.180

Fitriani, E. (2013). Faktor Resiko Yang Berhubungan Dengan kejadian Tuberkulosis Paru. Unnes Journal of Public Health. https://doi.org/10.15294/ujph.v2i1.3034

Irianti, Kuswandi, Yasin, N. M., & Kusumaningtyas, R. A. (2016). Mengenal Anti-Tuberkulosis. In Mengenal Anti-Tuberkulosis.

Joddy Sutama Putra, R., Achmad, A., & Rachma Pramestutie, H. (2017). Kejadian Efek Samping Potensial Terapi Obat Anti Diabetes Pada Pasien Diabetes Melitus Berdasarkan Algoritme Naranjo. Pharmaceutical Journal of Indonesia. https://doi.org/10.21776/ub.pji.2017.002.02.3

Kambuno, N. T., Senge, Y. H., Djuma, A. W., & Barung, E. N. (2019). Uji Tuberkulosis Laten Pada Kontak Serumah Pasien BTA Positif Dengan Metode Mantoux Test. JURNAL INFO KESEHATAN. https://doi.org/10.31965/infokes.vol17.iss1.239

Kemenkes RI. (2018). Tuberkulosis ( TB ). In Tuberkulosis.

Kurniawan, N. ’, HD, S. R., & Indriati, G. (2015). Faktor-Faktor yang Mempengaruhi Keberhasilan Pengobatan Tuberkulosis Paru. Jurnal Online Mahasiswa (JOM) Bidang Ilmu Keperawatan.

Noveyani, A. E., & Martini, S. (2014). (2014). Evaluasi Program Pengendalian Tuberkulosis Paru Dengan Strategi DOTS Di Puskesmas Tanah Kalikedinding Surabaya. Jurnal Berkala Epidemiologi.

Nurjana, M. A. (2015). Faktor Risiko Terjadinya Tubercolosis Paru Usia Produktif (15-49 Tahun) di Indonesia. Media Penelitian Dan Pengembangan Kesehatan.

Paneo, S. A. R. S., & Nursasi, A. Y. (2019). Pencegahan Tuberkulosis Paru dalam Keluarga: Kajian Literatur. Jurnal Penelitian Kesehatan “SUARA FORIKES” (Journal of Health Research “Forikes Voice”). https://doi.org/10.33846/sf10405

Pratiwi, E. P., Rohmawaty, E., & Kulsum, I. D. (2018). Efek Samping Obat Anti Tuberkulosis Kategori I dan II Pasien Tuberkolosis Paru Dewasa di Rumah Sakit Hasan Sadikin. Indonesian Journal of Clinical Pharmacy. https://doi.org/10.15416/ijcp.2018.7.4.252

Rusnoto, R. (2008). Faktor-Faktor Yang Berhubungan Dengan Kejadian Tb Paru Pada Usia Dewasa (Studi kasus di Balai Pencegahan Dan Pengobatan Penyakit Paru Pati). Jurnal Epidemiologi.

Sari, I. D., Yuniar, Y., & Syaripuddin, M. (2014). STUDI MONITORING EFEK SAMPING OBAT ANTITUBERKULOSIS FDC KATEGORI 1 DI PROVINSI BANTEN DAN PROVINSI JAWA BARAT. Media Penelitian Dan Pengembangan Kesehatan. https://doi.org/10.22435/mpk.v24i1.3484.28-35

Sarwani, D; Nurlaela, S; Zahrotul, I. (2012). ANALISIS FAKTOR RESIKO MULTIDRUG RESISTANT TUBERCULOSIS (MDR-TB) (STUDI KASUS DI BP4 PURWOKERTO). Jurnal Kesehatan Masyarakat.

Soepandi, P. (2014). Hasil Pengobatan dan Variasi Biaya TB-MDR/XDR dengan Strategi PMDT di RSUP Persahabatan. Jurnal Administrasi Rumah Sakit Indonesia. https://doi.org/10.1234/arsi.v1i1.2166

WHO. (2019). Global Tuberculosis Report 2019: Executive summary. In WHO Library Cataloguing-in-Publication Data World.




DOI: https://doi.org/10.31289/biolink.v8i1.4638

Article Metrics

Abstract view : 0 times
PDF - 0 times

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Fakultas Saintek, Program Studi Biologi, Universitas Medan Area

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License